electroCore to Participate in Upcoming Investor Conferences
08 Agosto 2024 - 7:00AM
electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic
medicine and wellness company, announced today that the Company’s
CEO, Dan Goldberger, is scheduled to participate in the 9th
Annual Needham Virtual MedTech & Diagnostics 1x1 Conference
August 12 - 13, 2024. Please contact Needham to schedule a 1x1
meeting.
In addition, Brian Posner, CFO of electroCore, Inc. is
scheduled to attend the 44th Annual Canaccord Genuity
Growth Conference taking place at InterContinental Hotel in
Boston, MA. electroCore will host 1x1 investor meetings
on August 13, 2024. Please contact Canaccord Genuity to
schedule a 1x1 meeting.
About electroCore, Inc.electroCore, Inc. is a
commercial stage bioelectronic medicine and wellness company
dedicated to improving health through its non-invasive vagus nerve
stimulation (“nVNS”) technology platform. Our focus is the
commercialization of medical devices for the management and
treatment of certain medical conditions and consumer product
offerings utilizing nVNS to promote general wellbeing and human
performance in the United States and select overseas
markets.
For more information, visit www.electrocore.com.
Contact:ECOR Investor Relations(973)
302-9253investors@electrocore.com
electroCore (NASDAQ:ECOR)
Gráfica de Acción Histórica
De Ago 2024 a Sep 2024
electroCore (NASDAQ:ECOR)
Gráfica de Acción Histórica
De Sep 2023 a Sep 2024